Treatment Strategies in Endogenous Fungal Endophthalmitis - Top_Thought_Leaders - MDSpire

Treatment Strategies in Endogenous Fungal Endophthalmitis

Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.

  • By

  • Arthi Venkat, MD, MS

  • Eleanor M. Burton, MD

  • January 1, 2026

  • 7 min

Share

Top Thought Leaders in Ophthalmology

Brief introduction explaining scope and methodology.

Original Source(s)

Treatment Strategies in Endogenous Fungal Endophthalmitis

  • by Arthi Venkat, MD, MS, Eleanor M. Burton, MD

  • January 1, 2026

Related Content

Efficacy of the 0.18 mg fluocinolone acetonide intravitreal implant in treating macular edema linked to non-infectious uveitis: Insights from a real-world analysis

Expanding the Role of Suprachoroidal Injections

Clinical data support this targeted route for small molecules, gene therapy, and oncologic agents, with a good safety profile and potential to reduce treatment burden.

Targeting IL-6 in the Treatment of Uveitic Macular Edema

Vamikibart shows promise as a new treatment for uveitic macular edema, improving vision and safety compared to existing steroids. Source: Dr. Rahul Khurana.